Viemed Healthcare, Inc.
VMDNasdaqCIK 1729149HealthcareFiscal year ends Dec 31
Reports and events: 134 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-11-0117:03 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001729149-23-000161 |
| 2023-11-0117:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001729149-23-000160 |
| 2023-08-1017:18 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001729149-23-000113 |
| 2023-08-0916:19 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001729149-23-000111 |
| 2023-08-0916:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001729149-23-000110 |
| 2023-08-0217:09 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001729149-23-000103 |
| 2023-06-1317:26 ET | 8-K | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001729149-23-000091 |
| 2023-06-0116:12 ET | 8-K | 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001729149-23-000086 |
| 2023-05-1817:21 ET | SC 13D/A | Ownership report, active investor, amended | 0001781905-23-000005 |
| 2023-05-0917:22 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001729149-23-000065 |
| 2023-05-0817:23 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001729149-23-000062 |
| 2023-05-0817:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001729149-23-000061 |
| 2023-04-2809:00 ET | DEF 14A | Proxy statementPeriod 2023-04-28 | 0001729149-23-000053 |
| 2023-04-1917:38 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001729149-23-000050 |
| 2023-03-0317:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001729149-23-000042 |
| 2023-03-0216:56 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001729149-23-000040 |
| 2023-03-0216:51 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001729149-23-000039 |
| 2023-01-2309:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001729149-23-000032 |
| 2023-01-1209:04 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001729149-23-000004 |
| 2022-11-2916:06 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001729149-22-000106 |
| 2022-11-0316:29 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001729149-22-000101 |
| 2022-11-0116:40 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001729149-22-000098 |
| 2022-11-0116:36 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001729149-22-000097 |
| 2022-08-0518:11 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001729149-22-000076 |
| 2022-08-0217:21 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001729149-22-000072 |
| 2022-08-0217:04 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001729149-22-000069 |
| 2022-08-0109:02 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001729149-22-000064 |
| 2022-07-0516:19 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001729149-22-000062 |
| 2022-06-0916:57 ET | 8-K | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001729149-22-000058 |
| 2022-05-1607:31 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001729149-22-000055 |
| 2022-05-0414:02 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001729149-22-000041 |
| 2022-05-0317:13 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001729149-22-000038 |
| 2022-05-0317:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001729149-22-000036 |
| 2022-04-2910:44 ET | DEF 14A | Proxy statementPeriod 2022-04-29 | 0001729149-22-000031 |
| 2022-03-0816:21 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001729149-22-000025 |
| 2022-03-0716:43 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001729149-22-000020 |
| 2022-03-0716:38 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001729149-22-000019 |
| 2021-11-0316:09 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001729149-21-000139 |
| 2021-11-0217:44 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001729149-21-000137 |
| 2021-11-0217:39 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001729149-21-000136 |
| 2021-09-1615:22 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001729149-21-000133 |
| 2021-08-0617:41 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001729149-21-000108 |
| 2021-08-0317:33 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001729149-21-000106 |
| 2021-08-0217:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001729149-21-000105 |
| 2021-06-1016:37 ET | 8-K | 3.03 Change to security holders’ rights; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001729149-21-000101 |
| 2021-05-2408:13 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001729149-21-000099 |
| 2021-05-0616:11 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001729149-21-000072 |
| 2021-05-0317:29 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001729149-21-000069 |
| 2021-05-0317:26 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001729149-21-000068 |
| 2021-04-3016:06 ET | DEF 14A | Proxy statementPeriod 2021-06-10 | 0001729149-21-000061 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 4, 2026, 19:03 ET. Listed shows no prices and gives no investment advice.